ネブライザーの世界市場 - 2025～2033年

ネブライザーの世界市場は2024年に15億7,000万米ドルに達し、2033年には24億9,000万米ドルに達すると予測され、予測期間2025年のCAGRは5.5%で成長します。

ネブライザーは、液体の薬剤を微細なミストに変換し、肺への直接吸入を可能にする医療機器です。この薬物送達技術は、喘息、慢性閉塞性肺疾患（COPD）、嚢胞性線維症、その他の肺疾患などの呼吸器疾患を患う患者に非常に有用です。エアロゾルの形で薬剤を投与するネブライザーは、呼吸器疾患のより迅速な吸収とより効果的な治療を可能にします。ネブライザーを使用する主な利点のひとつは、小さな子供や重度の呼吸器疾患を持つ患者など、通常の吸入器では困難な患者にもうまく薬剤を供給できることです。ネブライザーのミストは吸入を容易にし、吸入器で必要とされる特別な方法を必要としません。

呼吸器疾患の有病率の増加は、慢性呼吸器疾患の治療と管理において重要な役割を果たすため、ネブライザーの需要を増加させます。例えば、米国喘息・アレルギー財団によると、米国では約2,800万人が喘息に苦しんでいます。これは約12人に1人の割合に相当します。米国では、18歳以上の喘息患者が2,300万人近くいます。喘息は男性よりも女性に多いです。女性成人の約11.0％が喘息に罹患しており、男性成人の6.8％が喘息に罹患しています。喘息は若者の主要な慢性疾患です。現在、18歳未満の約490万人の子供が喘息を患っています。

市場力学：

促進要因と阻害要因

ネブライザー需要の増加

ネブライザーの需要増加は、世界のネブライザー市場の成長において重要な要因となることが予想されます。ネブライザーの需要増加は、呼吸器疾患の増加、技術の進歩、最近の製品発売、承認によるものです。

COPD、喘息、副鼻腔炎などの慢性呼吸器疾患が世界的に蔓延する中、ネブライザーは効果的なヘルスケア管理とクリティカルケアに必要です。例えば、保健福祉省によると、世界では20人に1人が慢性呼吸器疾患（CRD）を患っています。CRDによる死亡率が最も高いのは東アジアと南アジアです。また、社会人口統計指数（SDI）が低中位および低位の国では、年齢標準化したCRD死亡率が最も高いものとなりました。慢性呼吸器疾患（CRD）に関する新たな知見によると、CRDは世界第3位の死因であり、世界中で約400万人が死亡しています。このうち約60％（約2億6,200万人）が喘息と診断され、最も一般的なCRDとなっています。1990年以降、CRDの新規症例数は49.0％増加していますが、これは主に人口増加によるものです。一方、年齢標準化罹患率は5.3％減少しています。呼吸器疾患の増加はネブライザーの需要を増加させ、市場を牽引しています。

技術の進歩も需要増に大きな影響を与えています。振動メッシュ式ネブライザーの開発など、ネブライザーの設計における革新は、ドラッグデリバリーの効率と患者のコンプライアンスを向上させています。現代の技術は、旧世代よりも静かで、速く、コンパクトであることが多く、ユーザーにとってより魅力的なものとなっています。メーカーが高度な機能をもたらし、使用感を向上させるために研究開発を続けるにつれて、治療代替手段としてのネブライザーの魅力は確実に拡大すると思われます。例えば、2024年5月、Medline社は、呼吸器治療における薬物投与用のハドソンRCIターボミスト小容量ネブライザーを発売しました。Medline社は、TurboMistは3分以内に薬剤を投与できるため、市場最速の小容量ネブライザーであると主張しています。対照的に、従来のネブライザーは治療に少なくとも10分かかります。Medlineは、一般的なネブライザーよりも1分間に2.5倍多くの薬剤を投与できるTurboMistを開発しました。

デバイスの高コスト

デバイスのコストが高いなどの要因が、世界のネブライザー市場の妨げになると予想されます。主な懸念事項の一つは、ネブライザー、特にメッシュネブライザーのような複雑なタイプの初期費用が高いことです。コンプレッサー式ネブライザーは150ドルから300ドルもしますが、超音波式は通常50ドルから100ドルです。多くのユーザー、特に低所得の地域や層のユーザーは、コスト格差のために高品質のネブライザーを購入することができません。

このレポートの詳細について - サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • ネブライザー需要の増加
  • 抑制要因
  • ネブライザーに関連する制限
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 タイプ別

• ジェットネブライザー
• 超音波ネブライザー
• メッシュネブライザー

第7章 ポータビリティ別

• テーブルトップネブライザー
• ポータブルネブライザー

第8章 用途別

• 慢性閉塞性肺疾患
• 喘息
• その他

第9章 エンドユーザー別

• 病院
• 外来サービスセンター
• ホームケア

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• OMRON Healthcare
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• GE Healthcare
• Koninklijke Philips N.V.
• Allied Medical LLC
• Vectura Group Ltd
• PARI Respiratory Equipment, Inc.
• Aerogen
• Drive Devilbiss International
• Briggs Healthcare
• Beurer GmBH

第13章 付録

The global nebulizer market reached US$ 1.57 billion in 2024 and is expected to reach US$ 2.49 billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033.

A nebulizer is a medical device that converts liquid medication into a fine mist, allowing for direct inhalation into the lungs. This technique of medicine delivery is very useful for patients suffering from respiratory illnesses like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other pulmonary disorders. Nebulizers, which administer medication in aerosol form, allow for faster absorption and more effective treatment of respiratory disorders. One of the primary advantages of utilizing a nebulizer is its ability to deliver medication successfully to patients who may struggle with regular inhalers, such as small children or those with severe respiratory disorders. A nebulizer's mist makes inhalation easier and eliminates the need for particular methods required by inhalers.

The increasing demand for nebulizers is the driving factor that drives the market over the forecast period. the increasing prevalence of respiratory diseases increases the demand for nebulizers since they play a vital role in the treatment and management of chronic respiratory diseases. For instance, according to the Asthma and Allergy Foundation of America, Nearly 28 million people in the United States suffer with asthma. This equates to around one in every twelve people. Asthma affects almost 23 million persons in the United States, aged 18 and older. Asthma is more frequent in women than men. Asthma affects around 11.0% of female adults and 6.8% of male people. It is a major chronic disease among youngsters. Currently, around 4.9 million children under the age of 18 have asthma.

Market Dynamics: Drivers & Restraints

Increasing demand for nebulizers

The increasing demand for nebulizers is expected to be a significant factor in the growth of the global nebulizer market. The increasing demand for nebulizers is due to an increasing number of respiratory disorders, technological advancements, recent product launches, and approvals.

As chronic respiratory conditions like COPD, asthma, and sinusitis become more prevalent globally, nebulizers are necessary for effective healthcare management and critical care. For instance, according to the Department of Health & Human Services, 1 in 20 people globally suffers from chronic respiratory disease (CRD). East Asia and South Asia had the highest rates of CRD mortality. Low-middle and low Socio-demographic Index (SDI) countries had the highest age-standardized rates of CRD deaths. New findings on chronic respiratory disease (CRD) now show it is the third leading cause of death globally, accounting for approximately 4 million deaths worldwide. Asthma was diagnosed in approximately 60% of these people (approximately 262 million), making it the most common CRD. Since 1990, the number of new cases of CRDs has increased by 49.0%, owing primarily to population growth. The age-standardized incidence rate, on the other hand, has decreased by 5.3%. The increase in the number of respiratory disorders increases the demand for nebulizers and drives the market.

Technological advancements also have a major influence on increasing demand. Innovations in nebulizer design, such as the development of vibrating mesh nebulizers, have increased drug delivery efficiency and patient compliance. Contemporary technologies are frequently quieter, faster, and more compact than older generations, making them more enticing to users. As manufacturers continue to spend in research and development to bring sophisticated features and improve user experience, the attractiveness of nebulizers as a therapeutic alternative will most certainly expand. For instance, in May 2024, Medline has launched the Hudson RCI TurboMist small-volume nebulizer for administering medication in respiratory treatment. Medline claims that TurboMist is the fastest small-volume nebulizer on the market, as it can deliver medication in under three minutes. In contrast, traditional nebulizers can take at least 10 minutes to offer treatment. Medline created TurboMist to deliver 2.5 times more medication per minute than a typical nebulizer.

High costs of devices

Factors such as high costs of devices are expected to hamper the global nebulizer market. One of the primary concerns is the high initial cost of nebulizers, especially complex types like mesh nebulizers. Compressor nebulizers can cost anywhere from $150 to $300, although ultrasonic units are typically priced between $50 and $100. Many users, particularly those in lower-income regions or demographics, cannot manage to buy high-quality nebulizers due to cost disparities.

For more details on this report - Request for Sample

Segment Analysis

The global nebulizer market is segmented based on product type, portability, application, end-user, and region.

Jet nebulizer segment is expected to dominate the global nebulizer market share

The jet nebulizer segment is anticipated to dominate the global nebulizer market owing to its established presence, cost-effectiveness, and widespread acceptance among healthcare providers and patients. The affordable price of jet nebulizers is one of the primary reasons for their popularity. Jet nebulizers are often less expensive than other types of nebulizers, including ultrasonic and mesh nebulizers. This reduction in expenses makes them more accessible to a wider range of patients, especially in low- and middle-income nations where healthcare expenditures are constrained. The ability to provide effective aerosolized medication at lower expenses pushes healthcare facilities to use jet nebulizers as a common treatment option. The price of a basic jet nebulizer starts from $50 which is affordable by many people.

Jet nebulizers have an extended track record of being reliable and successful at delivering drugs. They are frequently used in hospitals and home care settings, so they are known to both healthcare providers and patients. Jet nebulizers are easy to use, allowing for effective control of respiratory disorders without the need for professional training for patients or caregivers. This familiarity adds to the sustained preference for jet nebulizers over the latest innovations, which may necessitate changes in usage patterns. The jet nebulizer maintains its dominance due to its affordability, dependability, and effectiveness in treating respiratory disorders.

Geographical Analysis

North America is expected to hold a significant position in the global nebulizer market share

The dominance of the North American market in the global nebulizer market is due to various factors such as advanced healthcare infrastructure, high prevalence of respiratory diseases, product launches, and approvals, and increasing adoption of nebulizers.

The increasing prevalence of respiratory disorders in this region increases the demand for nebulizers. For instance, according to health.gov, respiratory diseases affect millions of people in the United States. More than 25 million people in the United States have asthma. Strategies to reduce environmental triggers and make sure people get the right medications can help prevent hospital visits for asthma. In addition, more than 16 million people in the United States have COPD (chronic obstructive pulmonary disease), which is a major cause of death.

Furthermore, North America's well-established healthcare system contributes significantly to the nebulizer market. The region offers a large number of healthcare institutions equipped with the latest medical technologies, making nebulizers easily accessible to patients.

Asia Pacific is growing at the fastest pace in the global nebulizer market

The Asia Pacific region is emerging as the fastest-growing market for anesthesia and respiratory devices, owing to a combination of demographic trends, increased healthcare investment, and an increasing prevalence of respiratory diseases.

The increasing prevalence of respiratory diseases is one of the factors that drive the market in this region. For instance, according to The International Primary Care Respiratory Group, India has one of the highest rates of chronic respiratory illness. India accounts for 15.69% of worldwide chronic respiratory diseases, whereas 30.28% of all global deaths from chronic respiratory diseases occur in India. India has the world's greatest number of COPD (Chronic Obstructive Pulmonary Disease) cases, totaling 55.23 million. India has the second-highest number of COPD-related deaths globally, accounting for almost 0.85 million.

Competitive Landscape

The major global players in the global nebulizer market OMRON Healthcare, GE Healthcare, Koninklijke Philips N.V., Allied Medical LLC, Vectura Group Ltd, PARI Respiratory Equipment, Inc., Aerogen, Drive Devilbiss International, Briggs Healthcare, Beurer GmBH among others.

Emerging Players

Dr Morepen, Everycom Electronics, and Niscomed among others

Key Developments

• In January 2023, Synergy Life Science developed Nebi, a portable, battery-operated nebulizer for various applications, making it the first of its kind in the consumer health and wellness market.
• In November 2024, Students from the University of Karachi developed the world's smallest rechargeable nebulizer, an innovative device designed to offer convenience and ease of use for patients during travel or at the office. The nebulizer can operate continuously for 35 minutes and, once fully charged, remains functional for up to two days. This makes it a reliable and convenient option for individuals requiring frequent nebulization.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global nebulizer market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Portability
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increasing Demand for Nebulizers
  • 4.1.3. Restraints
  • 4.1.4. Limitations Associated with Nebulizers
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Jet Nebulizer*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Ultrasonic Nebulizer
• 6.4. Mesh Nebulizer

7. By Portability

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 7.1.2. Market Attractiveness Index, By Portability
• 7.2. Tabletop Nebulizer*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Portable Nebulizer

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. COPD*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Asthma
• 8.4. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Service Centres
• 9.4. Homecare

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. OMRON Healthcare*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. GE Healthcare
• 12.3. Koninklijke Philips N.V.
• 12.4. Allied Medical LLC
• 12.5. Vectura Group Ltd
• 12.6. PARI Respiratory Equipment, Inc.
• 12.7. Aerogen
• 12.8. Drive Devilbiss International
• 12.9. Briggs Healthcare
• 12.10. Beurer GmBH

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us